An E-platform for Learners

Pharma News

Breakthrough: New Injectable Therapy Could Prevent Heart Failure After Heart Attack Untitled

Untitled

Breakthrough: New Injectable Therapy Could Prevent Heart Failure After Heart Attack

Pharm'Up

Scientists from Northwestern University and the University of California San Diego have developed a groundbreaking, potent injectable...

Lupin Receives Tentative USFDA Approval for Generic HIV Treatment Drug

Lupin Receives Tentative USFDA Approval for Generic HIV Treatment Drug

Pharm'Up

Global pharmaceutical company Lupin Limited has announced that it has received Tentative Approval from the U.S. Food...

Glenmark Seals Multi-Billion Dollar Deal for Next-Gen HER2-Targeting Cancer Drug

Glenmark Seals Multi-Billion Dollar Deal for Next-Gen HER2-Targeting Cancer Drug

Pharm'Up

Glenmark Pharmaceuticals Ltd., through its wholly-owned subsidiary Glenmark Specialty S.A. (GSSA), has entered a major exclusive licensing...

Alkem Laboratories Launches Pertuza (Pertuzumab Biosimilar) in India to Boost Access to HER2-Positive Breast Cancer Treatment

Alkem Laboratories Launches Pertuza (Pertuzumab Biosimilar) in India to Boost Access to HER2-Positive Breast Cancer Treatment

Pharm'Up

Alkem Laboratories Ltd. has officially announced the launch of Pertuza injection 420mg/14mL, an indigenously-developed and manufactured biosimilar...

Montu Patel Removed as PCI President Following Ministry Order

Montu Patel Removed as PCI President Following Ministry Order

Pharm'Up

The Union Ministry of Health and Family Welfare has officially removed Montu Patel from his position as...

FDA Advances Approval of Leucovorin Calcium for Rare Neurological Disorder Linked to Autism

FDA Advances Approval of Leucovorin Calcium for Rare Neurological Disorder Linked to Autism

Pharm'Up

The U.S. Food and Drug Administration (FDA) has made a groundbreaking move toward approving leucovorin calcium tablets...

FDA Grants Accelerated Approval to Forzinity®, First Treatment for Rare Barth Syndrome

FDA Grants Accelerated Approval to Forzinity®, First Treatment for Rare Barth Syndrome

Pharm'Up

The U.S. Food and Drug Administration (FDA) has granted accelerated approval to Forzinity (elamipretide) injection, marking it...

FDA Rejects REXULTI® for PTSD, Citing Lack of ‘Substantial Evidence’ of Efficacy

FDA Rejects REXULTI® for PTSD, Citing Lack of ‘Substantial Evidence’ of Efficacy

Pharm'Up

The U.S. Food and Drug Administration (FDA) has issued a Complete Response Letter (CRL) to Otsuka Pharmaceutical...

GSK Pledges $30 Billion Investment in US R&D and Manufacturing, Focusing on Next-Gen Biopharma and AI Untitled

Untitled

GSK Pledges $30 Billion Investment in US R&D and Manufacturing, Focusing on Next-Gen Biopharma and AI

Pharm'Up

GSK plc has announced a monumental commitment to invest $30 billion in its research and development (R&D)...

Dr. Reddy’s Introduces Novel Acid-Blocker Tegoprazan (PCAB®) in India to Combat Widespread Acid Peptic Diseases

Dr. Reddy’s Introduces Novel Acid-Blocker Tegoprazan (PCAB®) in India to Combat Widespread Acid Peptic Diseases

Pharm'Up

Dr. Reddy’s Laboratories Ltd. has announced a significant advancement in the treatment of acid-related gastrointestinal diseases in...